All News 10x Genomics, Inc.

Equities

TXG

US88025U1097

Real-time Estimate Cboe BZX Other stock markets 11:14:44 2024-06-06 am EDT			5-day change	1st Jan Change
22.12 ^USD	-0.34%		-1.25%	-60.45%

Jun. 03	Jefferies Initiates 10x Genomics at Hold Rating With $24 Price Target	MT
May. 29	10x Genomics, Inc. Launches 5,000-Plex Gene Panel for Xenium	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Initiates 10x Genomics at Hold Rating With $24 Price Target	Jun. 03	MT
PTAB Denies IPR Petition For Failure To Construe Claims	May. 31	AQ
10x Genomics Launches 5,000-Plex Gene Panel for Xenium	May. 29	PR
10x Genomics, Inc. Launches 5,000-Plex Gene Panel for Xenium	May. 29	CI
UPC Court Of Appeal Defines Timeline And Justification For Changing The Language Of Proceedings	May. 29	AQ
Transcript : 10x Genomics, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 04:20 PM	May. 14
Dusseldorf Local Division Of The UPC Confirms That There Is No Prosecution History Estoppel In UPC Proceedings	May. 14	AQ
Bruker's NanoString Secures Patent Case Win in Germany	May. 07	MT
10x Genomics to Present at the BofA Securities 2024 Healthcare Conference	May. 02	PR
Olden Labs Launches The World's First Automated Animal Research Lab	May. 02	AQ
North American Morning Briefing : Stock Futures -2-	May. 02	DJ
UBS Adjusts 10x Genomics Price Target to $30 From $52, Maintains Neutral Rating	May. 01	MT
10x Genomics : First Quarter 2024 Prepared Remarks	Apr. 30	PU
Earnings Flash (TXG) 10X GENOMICS Reports Q1 Revenue $141M, vs. Street Est of $142.1M	Apr. 30	MT
10x Genomics: Q1 Earnings Snapshot	Apr. 30	AQ
Transcript : 10x Genomics, Inc., Q1 2024 Earnings Call, Apr 30, 2024	Apr. 30
10x Genomics Reports First Quarter 2024 Financial Results	Apr. 30	PR
10x Genomics, Inc. Reaffirms Revenue Guidance for the Year 2024	Apr. 30	CI
10x Genomics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 30	CI
Canaccord Genuity Adjusts Price Target on 10x Genomics to $50 From $65, Maintains Buy Rating	Apr. 29	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News 10x Genomics, Inc.

Equities

TXG

US88025U1097

All News

Filters